Mesothelioma surgery remains an area of great clinical controversy and debate which is only undertaken by a relatively small number of enthusiasts. Nevertheless the disease is an increasing health threat in the Western World and is likely to affect industrial nations across Asia in the rest of this century. There has been and continues to be many active research programs intended to further evidence-based medicine for mesothelioma. This special issue “Mesothelioma Surgery”, guest edited by Dr. David Waller and Dr. Annabel Sharkey, will focus on specific practice questions and their answers provided by leaders in those particular fields.
What is the contemporary role for surgery in the management of malignant pleural mesothelioma?
Complications following radical surgery for malignant pleural mesothelioma—prevention and management
Induction or adjuvant chemotherapy for radical multimodality therapy
There is insufficient evidence to support a screening programme for malignant pleural mesothelioma
Should the surgical decision be influenced by the diagnostic biopsy in mesothelioma?
Advances in mesothelioma imaging and implications for surgical management
Modern diagnostic and therapeutic interventional pulmonology in mesothelioma
Video-assisted thoracoscopic surgery in the management of mesothelioma
Patient selection for radical surgery for mesothelioma—prognostic factors in a multimodality approach
Surgical trials in mesothelioma—past, present and future
Surgical technique of pleurectomy/decortication
Technical aspects of extrapleural pneumonectomy
What are the implications of the revised N staging system for surgery?
Induction radiotherapy and mesothelioma surgery
Disclosure:
The series “Mesothelioma Surgery” was commissioned by the editorial office, Shanghai Chest without any sponsorship or funding. David Waller and Annabel Sharkey served as the unpaid Guest Editors for the series.